Jointown Pharmaceutical Group Co., Ltd (SHA: 600998)
China flag China · Delayed Price · Currency is CNY
5.52
+0.15 (2.79%)
Nov 20, 2024, 3:00 PM CST

Jointown Pharmaceutical Group Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
2,0472,1742,0852,4483,0751,727
Upgrade
Depreciation & Amortization
732.95732.95736.28656.81514.33497.06
Upgrade
Other Amortization
83.5183.5146.2646.7442.2939.67
Upgrade
Loss (Gain) From Sale of Assets
-6.92-6.92-48.23-6.72-258.03-7.22
Upgrade
Asset Writedown & Restructuring Costs
2.992.992.562.350.696.39
Upgrade
Loss (Gain) From Sale of Investments
37.437.4-308.25-1,456-1,231-134.35
Upgrade
Provision & Write-off of Bad Debts
131.87131.87160.56201.32184.764.16
Upgrade
Other Operating Activities
-2,0871,2421,6421,3691,4811,350
Upgrade
Change in Accounts Receivable
1,3311,331-4,446-2,971-4,159-2,427
Upgrade
Change in Inventory
-2,828-2,828-1,633-720.4-737.5-1,055
Upgrade
Change in Accounts Payable
1,8801,8805,9333,7244,3052,731
Upgrade
Change in Other Net Operating Assets
104.4104.494.36---
Upgrade
Operating Cash Flow
1,2914,7483,9863,4593,4442,768
Upgrade
Operating Cash Flow Growth
-79.37%19.10%15.24%0.44%24.42%126.50%
Upgrade
Capital Expenditures
-974.29-1,049-1,243-1,386-1,457-1,192
Upgrade
Sale of Property, Plant & Equipment
164.44163.42160.85171.49298.6217.68
Upgrade
Cash Acquisitions
-22.98-61.27-286.29-28.5882.5115.34
Upgrade
Divestitures
27.6634.57126.75-22.72-79.5645.18
Upgrade
Investment in Securities
-1,079-484.572,805-1,382-195.33-232.2
Upgrade
Other Investing Activities
-6.9835.54-75.28105.375.96105.83
Upgrade
Investing Cash Flow
-1,892-1,3611,488-2,543-1,275-1,240
Upgrade
Short-Term Debt Issued
-2,1243,2803,311913.21,153
Upgrade
Long-Term Debt Issued
-17,77219,74818,46722,39223,932
Upgrade
Total Debt Issued
19,76119,89623,02821,77723,30625,085
Upgrade
Short-Term Debt Repaid
--4,251-1,582-1,004-1,521-89.31
Upgrade
Long-Term Debt Repaid
--18,122-23,295-20,258-22,905-26,524
Upgrade
Total Debt Repaid
-23,606-22,373-24,877-21,263-24,425-26,614
Upgrade
Net Debt Issued (Repaid)
-3,845-2,477-1,849514.42-1,120-1,529
Upgrade
Issuance of Common Stock
1,776461.59195.35143.68--
Upgrade
Repurchase of Common Stock
---425.76-0.11-300.01-600.01
Upgrade
Common Dividends Paid
-1,596-1,635-1,388-1,682-737.68-1,140
Upgrade
Other Financing Activities
7,0793,413-1,433-993.651,974426.63
Upgrade
Financing Cash Flow
1,415-2,237-4,901-2,017-183.54-2,842
Upgrade
Foreign Exchange Rate Adjustments
-2.5-1.019.6-3.5-3.480.71
Upgrade
Net Cash Flow
811.481,149582.99-1,1051,982-1,314
Upgrade
Free Cash Flow
316.593,6992,7432,0731,9871,576
Upgrade
Free Cash Flow Growth
-93.93%34.86%32.32%4.33%26.09%-
Upgrade
Free Cash Flow Margin
0.21%2.46%1.95%1.69%1.79%1.58%
Upgrade
Free Cash Flow Per Share
0.060.730.520.400.370.28
Upgrade
Cash Income Tax Paid
2,8793,0192,5712,2951,9201,797
Upgrade
Levered Free Cash Flow
1,8721,4662,9622,729-802.282,164
Upgrade
Unlevered Free Cash Flow
2,6642,2903,7253,445-160.132,939
Upgrade
Change in Net Working Capital
-132.89291.97-1,723-2,1181,639-1,533
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.